CINECA IRIS Institutional Research Information System

BOCCACCIO, Carla
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.848
EU - Europa 2.533
AS - Asia 1.807
OC - Oceania 37
AF - Africa 17
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.261
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.767
CN - Cina 1.092
IT - Italia 731
DE - Germania 276
IE - Irlanda 254
SE - Svezia 234
FR - Francia 175
GB - Regno Unito 175
FI - Finlandia 155
SG - Singapore 155
UA - Ucraina 151
JP - Giappone 139
KR - Corea 127
CA - Canada 64
NL - Olanda 62
IN - India 58
PL - Polonia 57
ES - Italia 51
BE - Belgio 46
HK - Hong Kong 46
CH - Svizzera 40
ID - Indonesia 36
AU - Australia 33
TW - Taiwan 31
VN - Vietnam 30
RU - Federazione Russa 23
AT - Austria 20
IR - Iran 16
TH - Thailandia 14
DK - Danimarca 13
IL - Israele 13
TR - Turchia 12
MX - Messico 11
RO - Romania 11
BR - Brasile 10
MY - Malesia 10
NO - Norvegia 10
GR - Grecia 8
CZ - Repubblica Ceca 6
PT - Portogallo 6
RS - Serbia 6
DZ - Algeria 5
HU - Ungheria 5
IQ - Iraq 5
PE - Perù 5
JO - Giordania 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
SN - Senegal 4
EG - Egitto 3
LU - Lussemburgo 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
DM - Dominica 2
EE - Estonia 2
EU - Europa 2
GL - Groenlandia 2
LK - Sri Lanka 2
MA - Marocco 2
PH - Filippine 2
SA - Arabia Saudita 2
SI - Slovenia 2
AR - Argentina 1
BY - Bielorussia 1
CO - Colombia 1
CR - Costa Rica 1
GE - Georgia 1
HR - Croazia 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
LY - Libia 1
ME - Montenegro 1
MT - Malta 1
NG - Nigeria 1
NP - Nepal 1
PR - Porto Rico 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
Totale 8.261
Salva come PNG Salva come JPEG
Città #
Chandler 542
Ann Arbor 391
Beijing 298
Dublin 244
Fairfield 186
Ashburn 174
Houston 149
Shanghai 140
Singapore 110
Dearborn 108
Redwood City 106
Torino 100
Wilmington 95
Turin 92
Jacksonville 90
Princeton 87
Woodbridge 86
Milan 80
Seattle 80
Villeurbanne 80
Medford 77
Guangzhou 63
Cambridge 58
New York 58
Nyköping 57
Warsaw 51
Tokyo 48
Nanjing 42
Wuhan 37
Boston 36
Pisa 36
Hangzhou 35
Rome 31
Jakarta 30
Boardman 29
Fremont 25
Chengdu 24
Brussels 22
Dong Ket 22
Hefei 21
Verona 20
Vienna 20
Changsha 19
Helsinki 19
San Diego 19
London 18
Paris 18
Santa Clara 18
Chicago 17
Shenyang 16
Genoa 15
Luni 15
Ottawa 15
Zhengzhou 15
Lappeenranta 14
Madrid 14
Taipei 14
Toronto 14
Falls Church 13
Jinan 13
Los Angeles 13
Naples 13
Xian 13
Cossato 12
Munich 12
Seoul 12
Utrecht 12
Zurich 12
Amsterdam 11
Florence 10
Norwalk 10
Shenzhen 10
Washington 10
Catania 9
Hebei 9
Melbourne 9
Osaka 9
Carrara 8
Duncan 8
Fuzhou 8
Lachine 8
Stockholm 8
Suzhou 8
Bangkok 7
Bern 7
Chongqing 7
Edinburgh 7
Hong Kong 7
Kunming 7
Nashville 7
Padova 7
Phoenix 7
Rochester 7
San Jose 7
Tianjin 7
Barcelona 6
Belgrade 6
Bethesda 6
Central 6
Central District 6
Totale 4.714
Salva come PNG Salva come JPEG
Nome #
Known and novel roles of the MET oncogene in cancer: A coherent approach to targeted therapy 1.524
Induction of MET by Ionizing Radiation and Its Role in Radioresistance and Invasive Growth of Cancer 737
Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer 327
Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer. 316
Genetic Evolution of Glioblastoma Stem-Like Cells From Primary to Recurrent Tumor 238
Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell–like phenotype 232
The MET oncogene is a functional marker of a glioblastoma stem cell subtype. 203
A molecularly annotated model of patient-derived colon cancer stem-like cells to assess genetic and non-genetic mechanisms of resistance to anti-EGFR therapy 172
MET signaling in colon cancer stem-like cells blunts the therapeutic response to EGFR inhibitors. 171
Wild-type p53 controls cell motility and invasion by dual regulation of MET expression. 155
TNF-α promotes invasive growth through the MET signaling pathway. 151
MET-Mediated Resistance to EGFR Inhibitors: An Old Liaison Rooted in Colorectal Cancer Stem Cells. 151
MET inhibition overcomes radiation resistance of glioblastoma stem-like cells 133
Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition 130
A differentiation switch for genetically modified hepatocytes. 124
The MET Oncogene in Glioblastoma Stem Cells: Implications as a Diagnostic Marker and a Therapeutic Target. 118
Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. 115
Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report 113
WHEN REGULATION FAILS: HOW CANCER ARISES 108
Cancer and blood coagulation 95
A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes 91
HGF/scatter factor selectively promotes cell invasion by increasing integrin avidity 87
Apoptosis enhancement by the HIV-1 Nef protein. 85
A functional role for hemostasis in early cancer development 82
I recettori per i fattori di crescita 81
Ets up-regulates MET transcription 79
Exploring the interplay between MET and Tumor Necrosis Factor alpha 79
The MET oncogene drives a genetic programme linking cancer to haemostasis 77
ERBB3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to ERBB3 targeting in glioblastoma 77
Ionizing radiation fosters cancer invasion through transcriptional up-regulation of the MET oncogene 76
Activation of the MET receptor attenuates doxorubicin-induced cardiotoxicity in vivo and in vitro 75
I RECETTORI PER I FATTORI DI CRESCITA 73
Tumor cell-derived Timp-1 is necessary for maintaining metastasis-promoting Met-signaling via inhibition of Adam-10. 73
Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors. 73
A disintegrin and metalloproteinase-10 (ADAM-10) mediates DN30 antibody-induced shedding of the met surface receptor 73
“Metastatic Cancer of Unknown Primary” or “Primary Metastatic Cancer”? 71
I RECETTORI PER I FATTORI DI CRESCITA 69
Derivation and charaterization of cancer initialling cells representative of metastatic colorectal cancer genetic heterogeneity 69
I FATTORI DI CRESCITA CONTROLLANO LA PROLIFERAZIONE CELLULARE 68
Hepatocyte growth factor is a regulator of monocyte-macrophage function 68
Invasive growth: a MET-driven genetic programme for cancer and stem cells 66
Fibroblast nemosis arrests growth and induces differentiation of human leukemia cells 65
Colorectal cancer stem cells, MET and metastasis 64
Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGF. 62
The HIV-1 nef protein interferes with phosphatidylinositol 3-kinase activation 1. 61
The long-lasting protective effect of HGF in cardiomyoblasts exposed to doxorubicin requires a positive feed-forward loop mediated by ERK1,2-TIMP1-STAT3 61
Ligand-independent tyrosine phosphorylation of the receptor encoded by the c-neu oncogene. 59
Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cells 57
Cerebrospinal fluid tumor DNA for liquid biopsy in glioma patients’ management: Close to the clinic? 57
ERBB3 as a therapeutic target in glioblastoma: overexpression can make the difference 56
Plasminogen-related growth factor and semaphorin receptors: a gene superfamily controlling invasive growth. 55
Genetic link between cancer and thrombosis 54
Scatter factors and invasive growth. 53
The MET Oncogene as a Therapeutical Target in Cancer Invasive Growth 53
The HGF receptor family: unconventional signal transducers for invasive cell growth. 52
L'oncogene MET e la cescita invasiva delle cellule staminali del cancro 52
Interactions between growth factor receptors and adhesion molecules: breaking the rules. 51
The MET oncogene drives a genetic programme for stem and cancer cells 51
GROWTH FACTORS AND CELL SIGNALLING 50
Growth Factor Receptors 47
Scatter factor-dependent branching morphogenesis: structural and histological features 45
MET, a driver of invasive growth and cancer clonal evolution under therapeutic pressure. 45
QUANDO FALLISCE LA REGOLAZIONE: L'INSORGENZA DEL CANCRO 43
L'oncogene MET regola programmi cellulari che legano il cancro all'emostasi 43
I recettori per i fattori di crescita 43
Oncogenes, cancer, and haemostasis 41
Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas 40
Scatter factors in tumor progression 40
Hepatocyte Growth Factor: A marker and a player in disseminated intravascular coagulation 38
Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs) 23
MET∆14 promotes a ligand-dependent, AKT-driven invasive growth 22
Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary 20
The PSI Domain of the MET Oncogene Encodes a Functional Disulfide Isomerase Essential for the Maturation of the Receptor Precursor 19
Liquid biopsy of cerebrospinal fluid enables selective profiling of glioma molecular subtypes at first clinical presentation 14
Correction to: Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs) 11
Protocol for in vitro establishment of heterogeneous stem-like cultures derived from whole human glioblastoma tumors 9
An mTOR feedback loop mediates the 'flare' ('rebound') response to MET tyrosine kinase inhibition 8
MicroRNA 483-3p overexpression unleashes invasive growth of metastatic colorectal cancer via NDRG1 downregulation and ensuing activation of the ERBB3/AKT axis 5
Totale 8.474
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.954
article - articoli 0
book - libri 0
conference - conferenze 1.467
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.421
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020970 0 0 55 91 68 172 158 86 105 117 72 46
2020/20211.156 85 67 97 79 111 66 115 55 132 105 102 142
2021/20221.405 100 111 100 103 102 71 103 92 81 69 251 222
2022/20231.804 176 121 80 161 153 341 156 151 194 46 140 85
2023/20241.145 171 144 60 85 77 161 61 74 18 78 100 116
2024/2025246 37 111 98 0 0 0 0 0 0 0 0 0
Totale 8.474